Showing 1781-1790 of 5316 results for "".
How Do You Compare? Financial Benchmarking Survey Measures Aesthetic Market
https://practicaldermatology.com/topics/practice-management/how-do-you-compare-financial-benchmarking-survey-measures-aesthetic-market/23002/Results of an annual benchmarking survey among medical aesthetic, dermatology, and medispa practices across the US.10 Things Dermatologists Need to Know About Treating Vitiligo Today
https://practicaldermatology.com/topics/pigmentary-disorders/10-things-dermatologists-need-to-know-about-treating-vitiligo-today/22988/New and emerging treatment approaches offer hope for this challenging condition.FAST ASK: Simplifying Challenging Conversations
https://practicaldermatology.com/topics/practice-management/fast-ask-simplifying-challenging-conversations/22982/SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes/22088/News and views from Music City SCALEProtecting Your Most Valuable Asset: Insurance
https://practicaldermatology.com/topics/practice-management/protecting-your-most-valuable-asset-insurance/20817/A refresher on what you need to know about term life, permanent (cash value) life, and disability insurance.Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Empathy and Transactional Medicine: Improving Patient and Physician Outcomes
https://practicaldermatology.com/topics/skin-cancer-photoprotection/transactional-medicine-improving-patient-and-physician-outcomes/20316/For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20409/Physician Spotlight: Vikash Oza, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vikash-oza-md/20358/Access to newer medications remains a challenge in pediatric dermatology patients.